Urinary stone risk factors in the descendants of patients with kidney stone disease

  • Thasinas Dissayabutra
  • Nuttiya Kalpongkul
  • Jakkhaphan Rattanaphan
  • Chanchai Boonla
  • Monpicha Srisa-art
  • Wattanachai Ungjaroenwathana
  • Piyaratana Tosukhowong
Original Article

Abstract

Background

Evidence has indicated that immediate family members of nephrolithiasis patients had high opportunity to develop stones. However, they are usually not regarded to be at risk, since it is unclear if there are any lithogenic abnormalities found in non-stone-forming nephrolithiasis relatives. Our aim was to investigate urinary metabolic abnormalities in the children of nephrolithiasis patients, compared with the general population.

Methods

The 24-h urinary metabolic profile was studied for 28 calcium oxalate nephrolithiasis patients (NL) and 46 of their descendants (ND), as well as 40 non-stone-forming volunteers (V) and 34 of their descendants (VD).

Results

There was no difference between age, gender, and serum creatinine between NL vs. V (parental groups) and ND vs. VD (descendant groups). High urinary oxalate in nephrolithiasis and urinary calcium in their descendants was detected. In addition, an elevated urinary excretion rate of calcium, phosphate, protein, and albumin, along with low citrate excretion and high urinary supersaturation was observed in both the nephrolithiasis patients and their descendants. Approximate 17.8–24.4% of the nephrolithiasis descendants had a urinary supersaturation higher than the nephrolithiasis level, but none was found in VD group. The level of urinary supersaturation index was correlated with urinary protein and albumin excretion in nephrolithiasis family.

Conclusion

It was demonstrated that nephrolithiasis offspring carried several urinary metabolic risks predisposing to stone formation which are similar to their parents, and about one in every five nephrolithiasis children had nephrolithiasis level urinary supersaturation.

Keywords

Nephrolithiasis Family Urinary supersaturation Hypercalciuria Hypocitraturia Heritability 

Notes

Acknowledgements

We would like to thank Assistant Professor Dr. Thavorn Supaprom and Assistant Professor Dr. Kaew Udomsirichakorn from the Department of Science, Ubon Ratchathani University, and Mrs. Darunee Boonthong and Mrs. Tasanee Klinhom, nurses from the Division of Urology, Department of Surgery, Sunpasitthiprasong Hospital, as well as Yang Bowei, a graduate student from the Department of Biochemistry, Faculty of Medicine, Chulalongkorn University for assisting in subject enrollment, follow-up and sample delivery. We have deep gratitude for all the subjects in this study for their participation, as well as Assistant Professor Dr. Phisit Prapunwattana, Head of the Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, the staff from our Department and the Research Affair of the Faculty of Chulalongkorn University for their assistance. Finally, we would like to thank Professor Yoshihide Ogawa for his kind recommendation about the investigation of urinary supersaturation.

Compliance with ethical standards

Ethical approval

All procedures performed in the present study involving human participation were approved by the Ethics Committee for Research in Human Subjects in the Fields of Thai Traditional and Alternative Medicine, and by Ethics committee of Sunpasitthiprasong Hospital. Written consent or assent was obtained from all participants after a detailed explanation of the procedures involved. In addition, parental approval was obtained at the same time for all descendant subjects.

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M (2003) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 70(4):273–277CrossRefPubMedGoogle Scholar
  2. 2.
    Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30(3):246–253CrossRefPubMedGoogle Scholar
  3. 3.
    Trinchieri A (2005) Bone mineral content in calcium renal stone formers. Urol Res 33(4):247–253CrossRefPubMedGoogle Scholar
  4. 4.
    West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 51(5):741–747CrossRefPubMedGoogle Scholar
  5. 5.
    Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci U S A 105(28):9841–9846CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Ratkalkar VN, Kleinman JG (2011) Mechanisms of stone formation. Clin Rev Bone Miner Metab 9(3–4):187–197CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Edvardsson VO, Palsson R, Indridason OS, Thorvaldsson S, Stefansson K (2009) Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol 43(5):420–424CrossRefPubMedGoogle Scholar
  8. 8.
    Ertan P, Tekin G, Oger N, Alkan S, Horasan GD (2011) Metabolic and demographic characteristics of children with urolithiasis in Western Turkey. Urol Res 39(2):105–110CrossRefPubMedGoogle Scholar
  9. 9.
    Marickar YM, Salim A, Vijay A (2009) Pattern of family history in stone patients. Urol Res 37(6):331–335CrossRefPubMedGoogle Scholar
  10. 10.
    Sritippayawan S, Borvornpadungkitti S, Paemanee A, Predanon C, Susaengrat W, Chuawattana D, Sawasdee N, Nakjang S, Pongtepaditep S, Nettuwakul C, Rungroj N, Vasuvattakul S, Malasit P, Yenchitsomanus PT (2009) Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population. Urol Res 37(3):141–146CrossRefPubMedGoogle Scholar
  11. 11.
    Bergsland KJ, Coe FL, White MD, Erhard MJ, DeFoor WR, Mahan JD, Schwaderer AL, Asplin JR (2012) Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int 81(11):1140–1148CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Saez-Torres C, Grases F, Rodrigo D, Garcia-Raja AM, Gomez C, Frontera G (2013) Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis. Pediatr Nephrol 28(4):639–645CrossRefPubMedGoogle Scholar
  13. 13.
    Park C, Ha YS, Kim YJ, Yun SJ, Lee SC, Kim WJ (2010) Comparison of metabolic risk factors in urolithiasis patients according to family history. Korean J Urol 51(1):50–53CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Kinder JM, Clark CD, Coe BJ, Asplin JR, Parks JH, Coe FL (2002) Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol 167(5):1965–1967CrossRefPubMedGoogle Scholar
  15. 15.
    Bergsland KJ, Kelly JK, Coe BJ, Coe FL (2006) Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol 291(3):F530–F536CrossRefPubMedGoogle Scholar
  16. 16.
    Koyuncu HH, Yencilek F, Eryildirim B, Sarica K (2010) Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence? Urol Res 38(2):105–109CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Remer T, Neubert A, Maser-Gluth C (2002) Anthropometry-based reference values for 24-h urinary creatinine excretion during growth and their use in endocrine and nutritional research. Am J Clin Nutr 75(3):561–569CrossRefPubMedGoogle Scholar
  18. 18.
    Saez-Torres C, Rodrigo D, Grases F, Garcia-Raja AM, Gomez C, Lumbreras J, Frontera G (2014) Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol. Pediatr Nephrol 29(7):1201–1208CrossRefPubMedGoogle Scholar
  19. 19.
    Ariceta G (2011) Clinical practice: proteinuria. Eur J Pediatr 170(1):15–20CrossRefPubMedGoogle Scholar
  20. 20.
    Kirejczyk JK, Porowski T, Konstantynowicz J, Kozerska A, Nazarkiewicz A, Hoppe B, Wasilewska A (2014) Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol 29(9):1575–1582CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Koyun M, Guven AG, Filiz S, Akman S, Akbas H, Baysal YE, Dedeoglu N (2007) Screening for hypercalciuria in schoolchildren: what should be the criteria for diagnosis? Pediatr Nephrol 22(9):1297–1301CrossRefPubMedGoogle Scholar
  22. 22.
    Hoppe B, Kemper MJ (2010) Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 25(3):403–413CrossRefPubMedGoogle Scholar
  23. 23.
    Tiselius HG (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47(4):255–259CrossRefPubMedGoogle Scholar
  24. 24.
    Ogawa Y, Hatano T (1996) Comparison of the Equil2 program and other methods for estimating the ion-activity product of urinary calcium oxalate: a new simplified method is proposed. Int J Urol 3(5):383–385CrossRefPubMedGoogle Scholar
  25. 25.
    Chuaypen N, Boonla C, Dissayabutra T, Predanon C, Ruangvejvorachai P, Waiwijit U, Tosukhowong P (2013) Increased intrarenal expression of sodium-dicarboxylate cotransporter-1 in nephrolithiasis patients with acidic urine pH. Asian Biomedicine 7(4):571–577Google Scholar
  26. 26.
    DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Erhard M, Minevich E (2006) Urinary metabolic evaluations in normal and stone forming children. J Urol 176(4 Pt 2):1793–1796CrossRefPubMedGoogle Scholar
  27. 27.
    Sakhaee K, Maalouf NM, Sinnott B (2012) Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab 97(6):1847–1860CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Arrabal-Polo MA, Arrabal-Martin M, Giron-Prieto MS, Poyatos-Andujar A, Garrido-Gomez J, Zuluaga-Gomez A, Arias-Santiago S (2012) Osteopenia/osteoporosis in patients with calcium nephrolithiasis. Urol Res 40(6):709–716CrossRefPubMedGoogle Scholar
  29. 29.
    Manz F, Kehrt R, Lausen B, Merkel A (1999) Urinary calcium excretion in healthy children and adolescents. Pediatr Nephrol 13(9):894–899CrossRefPubMedGoogle Scholar
  30. 30.
    Blaine J, Chonchol M, Levi M (2015) Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol 10(7):1257–1272CrossRefPubMedGoogle Scholar
  31. 31.
    Tosukhowong P, Yachantha C, Sasivongsbhakdi T, Ratchanon S, Chaisawasdi S, Boonla C, Tungsanga K (2008) Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients. Urol Res 36(3–4):149–155CrossRefPubMedGoogle Scholar
  32. 32.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S (2007) Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thail 90(4):688–698Google Scholar
  33. 33.
    Nakagawa Y, Carvalho M, Malasit P, Nimmannit S, Sritippaywan S, Vasuvattakul S, Chutipongtanate S, Chaowagul V, Nilwarangkur S (2004) Kidney stone inhibitors in patients with renal stones and endemic renal tubular acidosis in northeast Thailand. Urol Res 32(2):112–116CrossRefPubMedGoogle Scholar
  34. 34.
    Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W (2006) Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis 48(4):546–554CrossRefPubMedGoogle Scholar
  35. 35.
    Rudman D, Kutner MH, Redd SC 2nd, Waters WC, Gerron GG, Bleier J (1982) Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab 55(6):1052–1057CrossRefPubMedGoogle Scholar
  36. 36.
    Zuckerman JM, Assimos DG (2009) Hypocitraturia: pathophysiology and medical management. Rev Urol 11(3):134–144PubMedCentralPubMedGoogle Scholar
  37. 37.
    Tosukhowong P, Borvonpadungkitti S, Prasongwatana V, Tungsanga K, Jutuporn S, Dissayabutr T, Reungjui S, Sriboonlue P (2002) Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy. Clin Chim Acta 325(1–2):71–78CrossRefPubMedGoogle Scholar
  38. 38.
    Lee YJ, Cho S, Kim SR (2014) Association between serum bicarbonate levels and albuminuria in stage 3 and stage 4 chronic kidney disease: a cross-sectional study. Clin Nephrol 81(6):405–410CrossRefPubMedGoogle Scholar
  39. 39.
    Driver TH, Shlipak MG, Katz R, Goldenstein L, Sarnak MJ, Hoofnagle AN, Siscovick DS, Kestenbaum B, de Boer IH, Ix JH (2014) Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 64(4):534–541CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© IPNA 2018

Authors and Affiliations

  • Thasinas Dissayabutra
    • 1
  • Nuttiya Kalpongkul
    • 1
  • Jakkhaphan Rattanaphan
    • 1
  • Chanchai Boonla
    • 1
  • Monpicha Srisa-art
    • 2
  • Wattanachai Ungjaroenwathana
    • 3
  • Piyaratana Tosukhowong
    • 1
  1. 1.Department of Biochemistry, Faculty of MedicineChulalongkorn UniversityBangkokThailand
  2. 2.Department of Chemistry, Faculty of ScienceChulalongkorn UniversityBangkokThailand
  3. 3.Division of Urology, Department of SurgerySunpasitthiprasong HospitalUbon RatchathaniThailand

Personalised recommendations